AstraZeneca's key medicines, mainly cancer drugs, Lynparza, Tagrisso and Imfinzi, and diabetes medicine Farxiga are expected ...

AstraZeneca said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not ...

Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese ...

The company believes Chinese authorities are probing allegations that two current and two former employees had illegally ...

Pharmaceutical giant AstraZeneca said Thursday that the head of its China operations had been detained, after reports the ...

AstraZeneca shares recorded their biggest one-day drop since March 2020 on Tuesday following a report that dozens of senior ...

Two current and two former senior AstraZeneca Plc executives in the group’s China unit are under investigation in a probe ...

Chinese authorities detained AstraZeneca employees amid a probe into data privacy breaches and unlicensed drug sales, stock ...

Sarepta will discontinue its next generation of exon-skipping drugs for Duchenne muscular dystrophy over safety concerns, in ...

AstraZeneca’s stock price dropped by 8.4% during Tuesday’s trading in London after a report fueled fears of a potentially ...

AstraZeneca shares declined Tuesday after reports that senior executives in China were potentially implicated in an insurance ...